I'm not sure about how much overhead supply there is.

New Post Public Reply Private Reply Replies (1) Message Board
Drano F1ash #12617
I'm not sure about how much overhead supply there is. Although I am still solidly in the green, I am no longer up 250% in my IRA and up 400% in my trading account as I was before the dual attacks -- January and the libelous article. I have no plans whatsoever to sell any of the stock that I bought from much higher levels. It angers me and is painful to think how much higher my account balance was before the criminals took the stock down --but I'm not convinced that there are many still holding the stock who just want to sell it at break-even. I think it's more likely that those still holding know what they own.

Let's not forget that this is was Stage 2 of the takedown that started when CTIX was threatening the magic 5 mark that would have enabled some institutions to buy this stock. When we appeared to be poised for another run up -- boom --- they dropped the hammer with perfect timing, compliments of Seeking Alpha and the Rosen Law firm.

I ask again, as I repeatedly did on the other site until someone there decided to shut down some of us bullish posters:

WHO PROFITS?

Is it JUST the shorts' gang? We know that this well-orchestrated, well-funded move is not just some guy writing an article that should have been removed by Seeking Alpha's own guidelines (they say they want you to report factual inaccuracies -- yet when many did,, including the company and a researcher who has as he says literally more knowledge about it than anyone else, was it removed? Yes, the shorts have made a huge amount of money -- but why didn't they completely cover at 1.70ish?

We know that nothing has changed for the worse with the science. On the contrary, we have even more progress in clinical trials. 3 drugs in human trials for 4 indications, with tremendous chance of continued success and FDA approval for Brilacidin, and very early mind-blowing anecdotal evidence of efficacy for Kevetrin.

Why would anyone still be short?

Could it be that someone wants the share price down, so that a crappy financing deal or a terrible partnership deal can be forced on the company? Is this only partially about the immediate profits from scaring the stupid out of their shares? Why isn't the raid over?

I wonder, I wonder. But not very much.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fast Renovations Could Save Homeowners Big Bucks

Updated Category News Views 67

Speed Matters in Renovation Projects You ever been locked in that eternal waiting game with a renovation project? It's a killer for the wallet. Chapter Renovation's digging into this mess, showing how dragging out a project can cost homeowners plenty more than they bargained for. They've been pushing an average completion time of 38 weeks. Compare that to the chilling...

Continue Reading
UN Forum Unleashes LatAm CEO Coalition for Action

Updated Category News Views 109

Latin America Takes Center Stage When the UN turns its spotlight on a region, you know there's something afoot. Right in Montevideo, Uruguay, the United Nations Global Compact gathered a hefty crowd of over 300 leaders from diverse backgrounds—think business, finance, government, and academia. What they were brewing wasn’t just talk; it was about driving real change...

Continue Reading
Lululemon Faces Lawsuit Over Alleged Fraudulent Reporting

Updated Category News Views 173

What's Stirring the Pot for Lululemon? Talk about a rollercoaster. Over here, Lululemon (NASDAQ:LULU) is navigating turbulent waters, facing a class action lawsuit for alleged securities fraud. Investors who bought into the brand between March 18, 2026, and September 3, 2026, are now watching their investments drop, following what's claimed as misleading trumpet calls...

Continue Reading
TORM's Q3 Results Point to Strength Amid Global Chaos

Updated Category News Views 82

TORM Navigates Chaotic Waters With Impressive Earnings Alright, TORM's catching my eye here amidst what seems like a global logistical mess. These folks are proving that chaos can indeed be lucrative. Cranking out robust numbers in Q3 2026, they've managed to steer through the murky oil trade waters carved by US-Iran tensions. We're seeing TORM's time charter equivalent...

Continue Reading
Singtel, Ericsson Push 6G Healthcare to the Forefront

Updated Category News Views 104

Breaking Ground in Healthcare Tech Ah, what’s cooking in Singapore? On a day like today, when the tech giants Singtel and Ericsson get chummy with National University Health System (NUHS), we're looking at the kind of healthcare advancements that read like science fiction. They’ve signed an MOU to launch the National University XG AI Centre (NXAC) – a mouthful,...

Continue Reading
Exiger Lands $12M Deal with USAF for ICBM Insights

Updated Category News Views 27

Exiger's New Partnership: A $12M Heavyweight Move The Air Force isn’t about to let its guard down when it comes to those intercontinental ballistic missiles. Nope, the powers that be have decided it’s time to pump some serious dough into the chain that keeps those missiles ready to go, handing $12 million over to Exiger to light the path through the complex web of the...

Continue Reading
Hyundai Pushes Hydrogen Boundaries at 2026 Expo

Updated Category News Views 137

A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...

Continue Reading
Smartphone Durability: What Investors Need to Know

Updated Category News Views 79

When a Drop Becomes a Cost-Benefit Analysis As someone who’s been around the block more times than I care to count, here’s a nugget for you: we rarely think about all the little things that could drill a hole in our pockets until they do. Take smartphones, the ubiquitous little beasts we carry everywhere. An accidental drop, one moment you’re butterfingering it in...

Continue Reading
Minghui and ASKA Seal Major Licensing Deal for MHB018A

Updated Category News Views 207

Breaking New Ground in Thyroid Eye Disease Treatment If there's one thing that keeps the biopharma world on its toes, it's the relentless pursuit of groundbreaking treatments. And folks, let me tell you, the latest tie-up between Minghui Pharmaceutical and ASKA Pharmaceutical has struck a chord. This union with MHB018A at its core might be one of those watershed moments...

Continue Reading
New CMO Joins ARTHEx: Boosting Innovative RNA Focus

Updated Category News Views 26

ARTHEx Biotech's Strategic Expansion Looks like ARTHEx Biotech is shaking things up with some strategic moves by bringing in Dr. Christian Freitag as their new Chief Medical Officer. Now, if you’re knee-deep in the biotech game, you'll know that having someone like Freitag onboard is akin to adding a star player to your lineup. The guy's got more than two decades of...

Continue Reading

Top 5 Most Recently Viewed Articles

CrowdStrike and Fortinet Innovate Cybersecurity Integration

Updated Category News Views 121

Introduction to the Partnership CrowdStrike (NASDAQ: CRWD) recently entered a significant strategic partnership with Fortinet to enhance cybersecurity solutions spanning endpoint protection and firewall security. This collaboration aims to provide customers with advanced security measures that are both integrated and efficient, crucial in today's rapidly evolving threat...

Continue Reading
Monster Energy Powers UFC Freedom 250 Airborne

Updated Category News Views 38

Monster Energy Raises Stakes for UFC Freedom 250 If there's one thing Monster Energy knows, it's how to crank up the spectacle. In anticipation of the UFC Freedom 250 extravaganza, they've pulled a stunt that's both audacious and high-flying. Picture this: Hall of Famer Cowboy Cerrone and MMA legend Joanna J?drzejczyk free-falling with the U.S. Army Golden Knights. The...

Continue Reading
SRAD Faces Major Legal Woes; $800M Value Vanishes

Updated Category News Views 50

The Shockwave in Sportradar's Universe You wake up one day to find that $800 million vanished from a company's market cap. For Sportradar (NASDAQ:SRAD), this isn't some nightmare scenario—it's their brutal reality after accusations flew in like a barrage, led by activist short sellers Muddy Waters and Callisto Research. Activists Unleash Allegations On April 22, 2026,...

Continue Reading
Nikon and Astellas Forge Partnership for Innovative Imaging Access

Updated Category News Views 180

Nikon Instruments and Astellas Collaborate to Enhance Research Nikon Instruments Inc., a well-respected name in microscopy technology, has taken significant steps to support innovation by partnering with Astellas Innovation Management LLC. This collaboration offers unparalleled access to advanced imaging systems for companies residing at SakuLab, a hub dedicated to...

Continue Reading
Altimmune's Growth: Key Highlights from Recent Earnings Call

Updated Category News Views 108

Altimmune Announces Financial Results and Business Progress Altimmune, Inc. (NASDAQ: ALT) recently shared its financial results, highlighting substantial developments in their current programs. This call provided an in-depth overview of their second quarter outcomes and the advancements made toward their therapeutic initiatives. Introducing Key Speakers During the call,...

Continue Reading